0001415889-23-006359.txt : 20230407
0001415889-23-006359.hdr.sgml : 20230407
20230407163016
ACCESSION NUMBER: 0001415889-23-006359
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230406
FILED AS OF DATE: 20230407
DATE AS OF CHANGE: 20230407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kovacs Shane William Charles
CENTRAL INDEX KEY: 0001579397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 23809017
MAIL ADDRESS:
STREET 1: PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
form4-04072023_040409.xml
X0407
4
2023-04-06
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001579397
Kovacs Shane William Charles
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
false
true
false
false
CH. OPERATING & FINANCIAL OFF.
0
Common Stock
2023-04-06
4
P
0
10000
A
396197
D
The weighted average purchase price for the transaction reported was $3.4173, and the range of prices were between $3.375 and $3.42. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
Includes 5,000 shares acquired under the issuer's Employee Stock Purchase Plan.
/s/ John B. Moriarty, Jr., Attorney-in-Fact
2023-04-07